nach oben

Pediatric Nephrology

Erschienen in:

11.04.2017 | Editorial Commentary

Frequent hemodialysis: history of the modality and assessment of outcomes

verfasst von: Douglas M. Silverstein

Erschienen in: Pediatric Nephrology | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

About 660,000 individuals have end-stage renal disease in the USA, the vast majority of whom are receiving standard, in-center, thrice-weekly hemodialysis (HD). The morbidity and mortality among patients receiving standard HD remain unacceptably high. Studies conducted over the past two decades have provided a substantial amount of information on the advantages and drawbacks of providing more frequent HD treatment, either in-center or at home. In this article I summarize these studies, focusing special attention on the randomized, cross-over study assessing outcomes in children who received either frequent, in-center HD or traditional, thrice-weekly, in-center HD performed by Laskin et al. (Pediatr Nephrol doi:10.1007/s00467-017-3656-x, 2017).

Laskin BL, Huang G, King E, Geary DF, Licht C, Metlay JP, Furth SL, Kimball T, Mitsnefes M (2017) Short, frequent, 5 days per week in-center hemodialysis versus 3 days per week treatment: a randomized cross-over pilot trial through the Midwest Pediatric Nephrology Consortium. Pediatr Nephrol. doi:10.1007/s00467-017-3656-x

US Renal Data System (USRDS) (2015) 2015 USRDS annual data report, volume 2—ESRD in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda. Available at www.usrds.org

Lameire N, Van Biesen W (2010) Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol 6:75–82CrossRefPubMed

US Renal Data System (USRDS) (2009) 2009 annual data report. Atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda. Available at www.usrds.org

Scribner BH, Cole JJ, Ahmad S, Blagg CR (2004) Why thrice weekly dialysis? Hemodial Int 8:188–192CrossRefPubMed

McLaughlin K, Manns B, Mortis G, Hons R, Taub K (2003) Why patients with ESRD do not select self-care dialysis as a treatment option. Am J Kidney Dis 41:380–385CrossRefPubMed

Golper T (2001) Patient education: can it maximize the success of therapy? Nephrol Dial Transplant 16[Suppl 7]:20–24

Hemodialysis Adequacy 2006 Work Group (2006) Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48[Suppl 1]:S2–S90

Baillod R, Comty C, Shaldon S (1965) Over-night unattended haemodialysis in the home. Proc Eur Dial Transpl Assoc 2:99–109

10.

Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G (1992) Survival as an index of adequacy of dialysis. Kidney Int 41:1286–1291CrossRefPubMed

11.

Uldall R, Ouwendyk M, Francoeur R, Wallace L, Sit W, Vas S, Pierratos A (1996) Slow nocturnal home hemodialysis at the Wellesley hospital. Adv Ren Replace Ther 3:133–136PubMed

12.

Pierratos A, Ouwendyk M, Francoeur R, Wallace L, Sit W, Vas S, Pierratos A (1998) Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 9:859–868PubMed

13.

Kjellstrand CM, Buoncristiani U, Ting G, Traeger J, Piccoli GB, Sibai-Galland R, Young BA, Blagg CR (2008) Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years. Nephrol Dial Transplant 23:3283–3289CrossRefPubMed

14.

Locatelli F, Buoncristiani U, Canaud B, Kohler H, Petitclerc T, Zucchelli P (2005) Dialysis dose and frequency. Nephrol Dial Transplant 20:285–296CrossRefPubMed

15.

Lowrie EG, Laird NM, Parker TF, Sargent JA (1981) Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305:1176–1181CrossRefPubMed

16.

Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis (HEMO) Study Group (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010–2019CrossRefPubMed

17.

Unruh M, Benz R, Greene T, Yan G, Beddhu S, de Vita M, Dwyer JT, Kimmel PL, Kusek JW, Martin A, Rehm-McGillicuddy J, Teehan BP, Meyer KB, HEMO Study Group (2004) Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO study. Kidney Int 66:355–366CrossRefPubMed

18.

Rocco MV, Dwyer JT, Larive B, Greene T, Cockram DB, Chumlea WC, Kusek JW, Leung J, Burrowes JD, SL ML, Poole D, Uhlin L, HEMO Study Group (2004) The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO study. Kidney Int 65:2321–2334CrossRefPubMed

19.

Walsh M, Culleton B, Tonelli M, Manns B (2005) A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 67:1500–1508CrossRefPubMed

20.

Chan CT, Floras JS, Miller JA, Richardson RM, Pierratos A (2002) Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 61:2235–2239CrossRefPubMed

21.

Chan CT, Jain V, Picton P, Pierratos A, Floras JS (2005) Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int 68:338–344CrossRefPubMed

22.

Pierratos A (1999) Nocturnal home hemodialysis: an update on a 5-year experience. Nephrol Dial Transplant 14:2835–2840CrossRefPubMed

23.

Lockridge RS Jr, Spencer M, Craft V, Pipkin M, Campbell D, McPhatter L, Albert J, Anderson H, Jennings F, Barger T (2004) Nightly home hemodialysis: five and one-half years of experience in Lynchburg, Virginia. Hemodial Int 8:61–69CrossRefPubMed

24.

Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, Tonelli M, Donnelly S, Friedrich MG, Kumar A, Mahallati H, Hemmelgarn BR, Manns BJ (2007) Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 298:1291–1299CrossRefPubMed

25.

FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS (2010) In-center hemodialysis six times per week versus three times per week. N Engl J Med 363:2287–2300CrossRef

26.

Ayus JC, Mizani MR, Achinger SG, Thadhani R, Go AS, Lee S (2005) Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study. J Am Soc Nephrol 16:2778–2788CrossRefPubMed

27.

Weinhandl ED, Nieman KM, Gilbertson DT, Collins AJ (2015) Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. Am J Kidney Dis 65:98–108CrossRefPubMed

28.

Kotanko P, Garg AX, Depner T, Pierratos A, Chan CT, Levin NW, Greene T, Larive B, Beck GJ, Gassman J, Kliger AS, Stokes JB; FHN Trial Group (2015) Effects of frequent hemodialysis on blood pressure: results from the randomized frequent hemodialysis Network trials. Hemodial Int 19:386–401CrossRefPubMedPubMedCentral

29.

Buoncristiani U, Fagugli R, Ciao G, Ciucci A, Carobi C, Quintaliani G, Pasini P (1999) Left ventricular hypertrophy in daily dialysis. Miner Electrolyte Metab 25:90–94CrossRefPubMed

30.

Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, Unruh ML, Rocco MV, Chertow GM, Frequent Hemodialysis Network Trial Group (2012) Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol 7:782–794CrossRefPubMedPubMedCentral

31.

Chertow GM, Johansen KL, Lew N, Lazarus JM, Lowrie EG (2001) Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int 57:1176–1181CrossRef

32.

Kaysen GA, Greene T, Larive B, Mehta RL, Lindsay RM, Depner TA, Hall YN, Daugirdas JT, Chertow GM; FHN Trial Group (2012) The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial. Kidney Int 82:90–99

33.

Sikkes ME, Kooistra MP, Weijs PJ (2009) Improved nutrition after conversion to nocturnal home hemodialysis. J Ren Nutr 19:494–499CrossRefPubMed

34.

Rocco MV (2013) Does more frequent hemodialysis provide dietary Freedom? J Renal Nutr 23:259–262CrossRef

35.

McFarlane P, Komenda P (2011) Economic considerations in frequent home hemodialysis. Semin Dial 24:678–683CrossRefPubMed

36.

Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C (2002) Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 40:611–622CrossRefPubMed

37.

Kroeker A, Clark WF, Heidenheim AP, Kuenzig L, Leitch R, Meyette M, Muirhead N, Ryan H, Welch R, White S, Lindsay RM (2003) An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis 42:49–55CrossRefPubMed

38.

McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA (2003) The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int 64:1004–1011CrossRefPubMed

39.

McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA (2006) The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis. Kidney Int 69:798–805CrossRefPubMed

40.

Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, McAllister CJ, Van Wyck D, Kopple JD, Kalantar-Zadeh K (2008) Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 19:2193–2203CrossRefPubMedPubMedCentral

41.

Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A (1998) Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53:1404CrossRef

42.

Rodriguez-Benot A, Martin-Malo A, Alvarez-Lara MA, Rodriguez M, Aljama P (2005) Mild hyperphosphatemia and mortality in hemodialysis patients. Am J Kidney Dis 46:68–77CrossRefPubMed

43.

Block GA, Hulbert-Shearon TE, Levin NW, Port FK (1998) Association of serum phosphorus and calcium–phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607–617CrossRefPubMed

44.

Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M (2004) Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 44:34–38CrossRefPubMed

45.

Slinin Y, Foley RN, Collins AJ (2005) Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16:1788–1793CrossRefPubMed

46.

Jean G, Chazot C, Charra B (2006) Hyperphosphataemia and related mortality. Nephrol Dial Transplant 21:273–280CrossRefPubMed

47.

Daugirdas JT, Chertow GM, Larive B, Pierratos A, Greene T, Ayus JC, Kendrick CA, James SH, Miller BW, Schulman G, Salusky IB, Kliger AS, Frequent Hemodialysis Network (FHN) Trial Group (2012) Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol 23:727–738CrossRefPubMedPubMedCentral

48.

Ornt DB, Larive B, Rastogi A, Rashid M, Daugirdas JT, Hernandez A, Kurella Tamura M, Suri RS, Levin NW, Kliger AS, Frequent Hemodialysis Network Trial Group (2013) Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials. Nephrol Dial Transplant 28:1888–1898CrossRefPubMedPubMedCentral

49.

Lo JC, Bewck GJ, Kaysen GA, Chan CT, Kliger AS, Rocco MV, Chertow GM, Study FHN (2016) Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis. Hemodial Int. doi:10.1111/hdi.12489

50.

National Kidney Foundation: KDOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Available at http://www.kidney.org/professionals/kdoqi/guidelines_cvd/intradialytic.htm.

51.

Clavo C, Maule S, Mecca F, Quadri R, Martina G, Cavallo Perin P (2002) The influence of autonomic neuropathy on hypotension during hemodialysis. Clin Auton Res 12:84–87CrossRef

52.

Rocco MV, Lockridge RS, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS, Frequent Hemodialysis Network (FHN) Trial Group, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S (2011) The effects of frequent, nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 80:1081–1091CrossRef

53.

Jaber BL, Lee Y, Collins AJ, Hull AR, Kraus MA, McCarthy J, Miller BW, Spry L, Finkelstein FO, FREEDOM Study Group (2010) Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics, and Everyday-Dialysis Outcome Measurements) study. Am J Kidney Dis 56:531–539CrossRefPubMed

54.

Shoji T, Tsubakihara Y, Fujii M, Imai E (2004) Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 66:1212–1220CrossRefPubMed

55.

Murray AM, Tupper DE, Knopman DS (2006) Cognitive impairment in hemodialysis patients is common. Neurology 25:216–223CrossRef

56.

Tamura MK, Unruh ML, Nissenson AR, Larive B, Eggers PW, Gassman J, Mehta RL, Kliger AS, Stokes JB, Frequent Hemodialysis Network (FHN) Trial Group (2013) Effect of more frequent hemodialysis on cognitive function in the Frequent Hemodialysis Network trials. Am J Kidney Dis 61:228–237CrossRef

57.

Suri RS, Larive B, Garg AX, Hall YN, Pierratos A, Chertow GM, Gorodetskeya I, Kliger AS, FHN Study Group (2011) Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) Trials. Nephrol Dial Transplant 26:2316–2322CrossRefPubMedPubMedCentral

58.

Suri RS, Larive B, Sherer S, Eggers P, Gassman J, James SH, Lindsay RM, Lockridge RS, Ornt DB, Rocco MV, Ting GO, Kliger AS, Frequent Hemodialysis Network Trial Group (2013) Risk of vascular access complications with frequent hemodialysis. J Am Soc Nephrol 24:498–505CrossRefPubMedPubMedCentral

59.

Farrington K (2013) Commentary for ‘effect of frequent hemodialysis on residual kidney function: Frequent Hemodialysis Network (FHN) Trials. Kidney Int 83:787–789CrossRefPubMed

60.

Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS, FHN Trial Group (2013) Effect of frequent hemodialysis on residual kidney function. Kidney Int 83:949–958CrossRefPubMedPubMedCentral

61.

Axley B, Speranza-Reid J, Williams H (2012) Venous needle dislodgement in patients on hemodialysis. Nephrol Nurs J 39:435–445PubMed

62.

Pennsylvania Patient Safety Authority (2010) Hemodialysis administration: strategies to ensure safe patient care. Pennsylvania Patient Safety Authority 7:87–96

63.

U.S. Department of Health and Human Services (DHHS) and Centers for Medicare & Medicaid Services (CMS) (2008) Centers for Medicare & Medicaid Programs; conditions of coverage for end stage renal disease facilities; Final Rule (42 CFR Parts 405, 410, 413 et al.). Federal Register 71:20384. Retrieved from http://www.cms.hhs.gov/CfCsAndCoPs/Downloads/ESRDfinalrule0415.pdf

64.

Renal Physicians Association (2007) Health and safety survey to improve patient safety in end stage renal disease: Report of findings from the ESRD patient survey. Renal Physicians Association, Rockville

65.

Tennankore KK, d’Gama C, Faratro R, Fung S, Wong E, Chan CT (2015) Adverse technical events in home hemodialysis. Am J Kidney Dis 65:116–121CrossRefPubMed

Titel: Frequent hemodialysis: history of the modality and assessment of outcomes
verfasst von: Douglas M. Silverstein
Publikationsdatum: 11.04.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Pediatric Nephrology / Ausgabe 8/2017
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-017-3659-7

Neu im Fachgebiet Pädiatrie

23.04.2024 | Typ-1-Diabetes | Nachrichten

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Frequent hemodialysis: history of the modality and assessment of outcomes

Abstract

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2017

Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment

A case of gross hematuria with flank pain in a 16-year-old boy: Questions

Atypical thymic carcinoid manifesting with nephrotic-range proteinuria in a 7-year-old boy

Anemia in nephrotic syndrome: approach to evaluation and treatment

Facial swelling in a child on chronic hemodialysis: Answers

A contemporary approach to the prevention of peritoneal dialysis-related peritonitis in children: the role of improvement science

Neu im Fachgebiet Pädiatrie

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

Update Pädiatrie